Ireland will receive 500,000 Pfizer-BioNtech jabs from now until July, says European Commission President
DUBLIN: The European Union (EU) is considering additional doses of Pfizer-BioNTech vaccine as the delivery of Johnson & Johnson vaccine to Europe will be delayed, and the use of AstraZeneca has been suspended due to reports of unusual blood clots.
The European Commission announced yesterday that 50 million doses of the Pfizer vaccine would be delivered by April. These extra doses were planned to be delivered at the end of the year, but due to unforeseen circumstances, they are being delivered sooner. The doses will be distributed in EU countries based on population.
Ireland, which accounts for slightly more than 1% of the European Union’s population, will receive over 500,000 doses. Ireland is expected receive additional vaccine doses between April and July.
The European Commission President said that the commission is doing everything possible to help the vaccination roll-out in Europe and will increase vaccine supply in the coming weeks and months.
Ursula von der Leyen also praised the performance of BioNTech-Pfizer. “I want to thank BioNTech-Pfizer. It has proven to be a reliable partner. It has delivered on its commitments, and it is responsive to our needs,” she said.
Ms. von der Leyen also announced that it would begin negotiations with drugmaker Pfizer-BioNtech on a third contract for 1.8 billion vaccine doses over the 2021-23 period. She said the production of vaccines and all essential components would be in the EU. She added that there may be other contracts with other companies in the future.
Kindly click the link below to join WhatsApp group chat to get important news and breaking news from Irish Samachar
Comments are closed.